Enable critical diagnosis as early as possible for improved patient care
The cobas® HIV-1/HIV-2 Qualitative Test for use on the cobas® 5800/6800/8800 Systems is the first automated nucleic acid test to enable differentiation between HIV-1 and HIV-2 infections, applying the clinically proven dual target design (gag and LTR) for HIV-1. During seroconversion studies1 in 25 commercially available panels, cobas® HIV-1/HIV-2 detects HIV on average one week earlier than serology. cobas® HIV-1/HIV-2 offers flexible testing features, highest throughput and absolute automation with ready-to-use reagents.
cobas® HIV-1/HIV-2 Qualitative Test for 5800/6800/8800 Systems: CE-IVD
cobas® HIV-1/HIV-2 Qualitative Test for 5800/6800/8800 Systems: US-IVD
Access package inserts through your country’s Roche Diagnostics Website.
References:
1. cobas® HIV-1/HIV-2 Qualitative nucleic acid test for use on cobas® 5800/6800/8800 Systems Instructions for Use: 08020655001-05EN
Ready-to-use reagents loaded onto the cobas® 5800/6800/8800 Systems are stored at appropriate temperatures and their expiration is monitored by the system. The system automatically prevents use of expired reagents.